Mirena Lawsuit Update: Bayer Opposes Federal Case Consolidation, Rottenstein Law Group Reports

Mirena IUD manufacturer Bayer Healthcare Pharmaceuticals has filed a motion opposing the consolidation of federal Mirena lawsuits for purposes of pretrial proceedings, the Rottenstein Law Group reports after reviewing court documents (In re: Mirena IUD Products Liability Litigation, MDL-2434 (JPML)).

(PRWEB) February 15, 2013

Mirena IUD manufacturer Bayer Healthcare Pharmaceuticals has filed a motion opposing the consolidation of federal Mirena lawsuits for purposes of pretrial proceedings, the Rottenstein Law Group, a Mirena law firm, reports according to court documents (In re: Mirena IUD Products Liability Litigation, MDL-2434 (JPML)).

Bayer argues in the Feb. 7 filing (In re: Mirena IUD Products Liability Litigation, MDL-2434 (JPML)) that multidistrict litigation would prejudice the company for several reasons, among them that because Bayer has been preparing documents for discovery in an individual case for the past two years, it would now have to spend further time and money to go through the process again for a federal MDL case. The company argues also that the creation of an MDL would attract “marginal” claims against the company over its Mirena hormonal IUD.

Mirena has demonstrated the potential to cause women serious side effects, according to the FDA drug label.* These include device perforation (puncture of the uterine wall), migration (the shifting of the device outside of the woman’s uterus), and embedment (the device becomes stuck in the uterine wall).

“Women who believe the Mirena IUD has caused them to suffer should not be discouraged by Bayer’s motion,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, which represents clients in lawsuits related to the Mirena IUD. “We hear from several women each day who have suffered from Mirena’s alleged side effects, and encourage anyone who hasn’t called yet to contact us so we can help them evaluate if they have a case.”

In 2000, the U.S. Food and Drug Administration approved the Mirena IUD, which is plastic and uses a low dose of hormones as a contraceptive for up to five years. It was marketed specifically to women who have had children but do not want more. About two million women in the United States (and 15 million worldwide) use the device, according to Bloomberg. It was the last IUD the FDA approved until recently, when the regulatory body approved Bayer’s Skyla, a hormonal IUD similar to the Mirena but marketed to young women who haven’t yet given birth.

The Rottenstein Law Group, a personal injury firm, encourages Mirena IUD recipients to download an informational brochure from its website to learn more about the device and related lawsuits and to help them evaluate if they have a case.

*accessdata.fda.gov/drugsatfda_docs/label/2009/021225s027lbl.pdf

**bloomberg.com/news/2013-01-28/bayer-sued-over-alleged-hidden-risks-of-mirena-contraceptive-1-.html

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com